Orbimed Advisors LLC Ultragenyx Pharmaceutical Inc. Transaction History

Orbimed Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $10.4 Million - $19.4 Million	-227,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $14.2 Million - $19.2 Million	227,600 New	227,600 $16.5 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $30.1 Million - $38.2 Million	-834,313 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $32.1 Million - $47.6 Million	754,706 Added 948.04%	834,313 $35.7 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $4.37 Million - $5.92 Million	79,607 New	79,607 $5.06 Million
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $4.85 Million - $6.09 Million	-67,605 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $3.28 Million - $5.77 Million	67,605 New	67,605 $5.2 Million

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.04B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.